• Latest Posts

First subject dosed in inflammation phase I study

Deep Science Ventures and AbbVie to create companies to target inflammatory diseases

More News! 18 Nov 2022

Triastek cleared for 3D printed medicine treatment of ulcerative colitis

More News! 14 Nov 2022

BioSenic’s autoimmune disease platform adapting to meet unmet medical needs

EpiEndo gets regulatory approval for first patient study of first non-antibiotic macrolide

Researchers develop new nanoparticle to deliver drugs direct to macrophages


Lipum starts chronic inflammatory disease drug study

Delayed release tablets to treat ulcerative colitis launched in Canada

C4XD and HitGen to collaborate on inflammation hit identification project

NodThera reveals positive results for inflammasome inhibitors

Cyxone receives approval for phase 2b rheumatoid arthritis study

Domainex’ drug shows positive data for treatment of interferonopathies